Σύγκριση μεθόδων

	Έκθεση Αξιολόγησης Λειτουργικότητας Παιδικής Αρθρίτιδας (JAFAR)	Ερωτηματολόγιο Ποιότητας Ζωής Παιδιών με Άσθμα (PAQLQ)	Ενότητα PedsQL για τον Διαβήτη
Πεδίο	Παιδιατρική	Παιδιατρική	Παιδιατρική
Οικογένεια	Process / pipeline	Process / pipeline	Process / pipeline
Έτος προέλευσης	1989	1996	2003
Δημιουργός	David J. Lovell	E. F. Juniper	James W. Varni
Τύπος	Parent report of child functional status	Child self-report; parent version available	Child self-report and parent proxy
Θεμελιώδης πηγή	Lovell, D. J., Howe, S., Shear, E., Hartner, S., McGirr, G., Schulte, M., & Jaffe, R. (1989). Development of a disability measurement tool for juvenile rheumatoid arthritis. Arthritis & Rheumatism, 32(11), 1390-1395.	Juniper, E. F., Guyatt, G. H., Feeny, D. H., Ferrie, P. J., Griffith, L. E., & Townsend, M. (1996). Measuring quality of life in children with asthma. Quality of Life Research, 5(1), 35-46.	Varni, J. W., Burwinkle, T. M., Jacobs, J. R., Gottschalk, M., Kaufman, F., & Jones, K. L. (2003). The PedsQL in type 1 and type 2 diabetes: Reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales and type 1 Diabetes Module. Diabetes Care, 26(3), 631-637.
Εναλλακτικές ονομασίες	JAFAR, Juvenile Arthritis Functional Assessment Scale	PAQLQ-S	PedsQL 3.0 Diabetes
Συναφείς	4	4	5
Σύνοψη	The JAFAR is a parent-report instrument developed by Lovell et al. in 1989 to assess functional ability in children and adolescents with juvenile idiopathic arthritis (JIA). Measuring across multiple domains including lower extremity function, upper extremity function, and activities of daily living, the JAFAR quantifies the extent to which arthritis and its treatment affect the child's mobility, self-care, and participation in age-appropriate activities. It remains a standard functional outcome measure in pediatric rheumatology research and clinical practice.	The PAQLQ is a 23-item self-report instrument developed by Juniper et al. in 1996 to measure quality of life in children aged 7–17 years with asthma. It assesses how asthma and its treatment affect daily functioning, emotions, and activity levels. The instrument has become the gold standard for evaluating asthma-specific health-related quality of life in pediatric populations.	The PedsQL Diabetes Module is a 28-item disease-specific instrument developed by Varni et al. in 2003 to measure quality of life in children and adolescents with type 1 and type 2 diabetes. It captures the impact of diabetes management, glucose monitoring, and disease-related worry on daily functioning. The module is paired with the PedsQL Generic Core Scales, enabling both disease-specific and general health-related quality of life assessment.